6 Results for: created: (01/2018 to 01/2018)

People

  1. Riely
    Riely
  2. Drilon
    Drilon
  3. Kris
    Kris
  4. Ni
    Ni
  5. Yu
    Yu
  6. Ahn
    Ahn
  7. Arbour
    Arbour
  8. Beal
    Beal
  9. Buie
    Buie
  10. Bushnell
    Bushnell

Groups

  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. Thoracic Oncology (6)
  4. Biostatistics Service (3)
  5. Epidemiology and Biostatistics (3)
  6. Nursing (2)
  7. Radiology, Department of (2)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  9. Body Imaging Service (1)
  10. Center for Molecular Imaging and Biotechnology (1)
  1. "Gregory Riely"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
Groups
  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (6)
  3. Thoracic Oncology (6)
  4. Biostatistics Service (3)
  5. Epidemiology and Biostatistics (3)
  6. Nursing (2)

More Groups

People
  1. Gregory Riely (6)
  2. Ai Ni (2)
  3. Alexander Drilon (2)
  4. Helena Yu (2)
  5. Mark Kris (2)
  6. Andrew Plodkowski (1)

More People

Years
  1. 2018 (1)
  2. 2017 (5)
Publications
  1. Journal of Thoracic Oncology (4)
  2. Cancer (1)
  3. Neuro-Oncology (1)
Publishers
  1. Elsevier Inc. (4)
  2. Oxford University Press (1)
  3. Wiley Blackwell (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
    Journal Article

    Arbour, K. C.; Kris, M. G.; Riely, G. J.; Ni, A.; Beal, K.; Daras, M.; Hayes, S. A.; Young, R. J.; Rodriguez, C. R.; Ahn, L.; more...
    Cancer (2018)

    Fulltext@MSK | Save
  • Prognostic factors and outcomes of patients with central nervous system (CNS) metastatic ALK-rearranged non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Kachur, E.; Reiss, S.; Land, J.; Buie, L.; Reiner, A.; Panageas, K.; Riely, G.; Pentsova, E.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Clinical activity of osimertinib in EGFR mutation positive non-small cell lung cancer (NSCLC) patients (pts) previously treated with rociletinib
    Meeting Abstract

    Gadgeel, S.; Chen, W.; Piotrowska, Z.; Goldman, J. W.; Wakelee, H.; Camidge, D. R.; Varga, A.; Yu, H.; Papadimitrakopoulou, V.; Nea, J.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Antitumor activity and safety of crizotinib in patients with MET exon 14-altered advanced non-small cell lung cancer
    Meeting Abstract

    Drilon, A.; Ou, S. H.; Clark, J.; Camidge, D. R.; Socinski, M.; Weiss, J.; Solomon, B.; Riely, G.; Heist, R.; Shapiro, G.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Updated efficacy and safety data from the phase 2 NP28761 study of alectinib in ALK-positive non-small-cell lung cancer
    Meeting Abstract

    Camidge, D. R.; Gadgeel, S.; Ou, S. H.; Gandhi, L.; Riely, G.; Cetnar, J.; West, H.; Socinski, M.; Chiappori, A.; Mekhail, T.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • A phase 2 study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A.; Somwar, R.; Smith, R.; Delasos, L.; Albano, M.; Van Voorthuyson, M.; Wang, L.; Rekhtman, N.; Ni, A.; Plodkowski, A.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save